# FDA 483 - Groupe Parima Inc. - April 27, 2018

Source: https://www.keypedia.com/records/483/groupe-parima-inc/fc995c59-8b78-4361-8c67-5ceb1e039db1

> FDA 483 for Groupe Parima Inc. on April 27, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Groupe Parima Inc.
- Inspection Date: 2018-04-27
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I
- Summary: An FDA inspection of Groupe Parima Inc. in Montreal revealed significant deficiencies in data integrity, equipment maintenance, and facility upkeep. The firm failed to ensure electronic data backup integrity, perform routine equipment checks, and maintain its manufacturing buildings in a good state of repair. These observations indicate a lack of adherence to good manufacturing practices for drug products.

## Related Documents

- [483 - 2020-01-24](https://www.keypedia.com/records/483/groupe-parima-inc/586024ac-2f77-4e9d-8c0a-bccdb6402e6c)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)

Company: https://www.keypedia.com/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23

Office: https://www.keypedia.com/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1